Page 6 - Sales Value News Today

Share this article Share this article ResearchAndMarkets.coms offering. Iodixanol is a third-generation contrast agent that has good solubility and is isotonic to plasma. It is used for cardiovascular angiography, cerebrovascular angiography, abdominal angiography, and so on. Iodixanol was developed by Nycomed, a Norwegian company, naming VISIPAQUE (Nycomed was acquired by GE after the merge with Amersham, and become GE Healthcare). In 2001, Iodixanol entered the Chinese market. Currently, bes...

Share this article Share this article ResearchAndMarkets.coms offering. Trastuzumab is a monoclonal antibody used to treat breast cancer and stomach cancer, and is especially used for the treatment of certain HER-2 positive cancers. The original drug, HERCEPTIN was developed by Roches subsidiary corporation. In 2002, Trastuzumab entered the Chinese market. Currently, besides Roche, the other main manufacturer in the Chinese market is Shanghai Henlius Biotech, Inc. According to this market rese...

South Africa Tampons (Feminine Hygiene) Market Market Projected to Show Strong Growth by 2026

Share this article Share this article ResearchAndMarkets.coms offering. Sales of Budesonide increased from 2016 to 2019, with a CAGR of approximately 9.26%. However, the sales of Budesonide decreased by 29.30% in 2020 because of the COVID-19 pandemic. The sales revenue in 2020 was approximately CNY1.1 billion. With the improvement of the epidemic situation, the analyst predicts that the sales of Budesonide in China will have a recovery growth in the short run. Budesonide is an adrenal cortex ho...

Share this article Share this article ResearchAndMarkets.coms offering. Dezocine is an opioid analgesic that relieves pain. Dezocine was launched in China in 2009 and has been widely used in general anesthesia induction, postoperative analgesia, and preemptive analgesia. According to the analysts market research, the sales of Dezocine had a growth trend from 2016 to 2019. The revenue in 2020 was approximately CNY2.06 billion, though it decreased by 6.18% compared to 2019 due to the COVID-19 ep...

China Dezocine Market Investigation Report 2021-2025: Revenue in 2020 was Approximately CNY2.06 Billion, though it Decreased by 6.18% Compared to 2019 Due to the COVID-19 Epidemic April 30, 2021 04:48 ET | Source: Research and Markets Research and Markets Dublin, IRELAND ResearchAndMarkets.coms offering. Dezocine is an opioid analgesic that relieves pain. Dezocine was launched in China in 2009 and has been widely used in general anesthesia induction...

Share this article Share this article ResearchAndMarkets.coms offering. In 2021-2025, the Chinese ambroxol market will gradually recover. It is estimated that the sales of ambroxol in China will reach CNY924 million in 2025, and the CAGR will reach 10% in 2021-2025. Due to the outbreak of COVID-19 in 2020, the ability of Chinese hospitals to receive patients has declined. The decrease in the number of people seeking medical care makes Chinas sales and sales of ambroxol show a downward trend in ...

Share this article Share this article ResearchAndMarkets.coms offering. In 2021-2025, the Chinese ambroxol market will gradually recover. It is estimated that the sales of ambroxol in China will reach CNY924 million in 2025, and the CAGR will reach 10% in 2021-2025. Due to the outbreak of COVID-19 in 2020, the ability of Chinese hospitals to receive patients has declined. The decrease in the number of people seeking medical care makes Chinas sales and sales of ambroxol show a downward trend in ...

/Global Stem Cell Therapy Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026 Global Stem Cell Therapy Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2015-2026 As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. sahilFebruary 25, 2021 Summary ...

2 Global Physician Practice Management Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026) 2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026) 3 Regional Market Analysis 3.1.1 Top Companies leading Physician Practice Management Development in China (2015-2020) 3.1.2 Sales Value of Major Company in China Market (2015-2020) 3.1.3 Ch...